Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Epilepsy Drug Study Showing Little Risk May Help Vivus Pill
Bloomberg
Tuesday, May 17, 2011 - 8:53pm
tags:
Vivus, epilepsy, Qnexa
AstraZeneca: The Street Is too Pessimistic on This High Dividend Big Pharma Stock
Seeking Alpha
Tuesday, May 17, 2011 - 8:52pm
tags:
AstraZeneca, GSK, Merck, Bristol-Myers Squibb
CytRx touts "game changing" $120M pact with Orphazyme
Fierce Biotech
Tuesday, May 17, 2011 - 1:08pm
tags:
Orphazyme, CytRx
Dendreon Presents Additional Provenge Safety Data
Minyanville
Tuesday, May 17, 2011 - 1:01pm
tags:
Provenge, Dendreon, prostate cancer
Forest shareholder demands CEO's resignation
Fierce Pharma
Tuesday, May 17, 2011 - 12:59pm
tags:
Pharma CEOs, shareholders, Forest Labs, Howard Solomon
Teva Pharmaceutical: Cornering Japan's Generics Market
Seeking Alpha
Tuesday, May 17, 2011 - 12:57pm
tags:
Teva Pharmaceuticals, Japan, Taiyo, M&A
Are You Watching this Trend at Novo Nordisk A/S?
Motley Fool
Tuesday, May 17, 2011 - 12:56pm
tags:
Novo Nordisk
Merck Girds For Hep C Battle With Roche Deal
TheStreet.com
Tuesday, May 17, 2011 - 12:55pm
tags:
Merck, hepatitis C, Roche, Victrelis, Boceprevir, Pegasys, Vertex Pharmaceuticals
Is Johnson & Johnson Earning Enough for You?
Motley Fool
Tuesday, May 17, 2011 - 12:53pm
tags:
JNJ
Amgen: Xgeva Delays Cancer Spread to Bone
TheStreet.com
Tuesday, May 17, 2011 - 12:52pm
tags:
Xgeva, Amgen, prostate cancer
Sanofi’s Genzyme Sues Allergan for Royalties on Juvederm
Bloomberg
Tuesday, May 17, 2011 - 9:57am
tags:
Sanofi, Genzyme, Allergan, Juvederm
More signs diabetes drug Actos linked to bladder cancer
Reuters
Tuesday, May 17, 2011 - 9:56am
tags:
Actos, diabetes, bladder cancer
Abbott Drug Faces U.S. Scrutiny Over Lack of Heart Benefits
Bloomberg
Tuesday, May 17, 2011 - 9:53am
tags:
Abbott Laboratories, Triplix
Pfizer seeks US, Japan approval of cancer drug
Yahoo/AP
Tuesday, May 17, 2011 - 9:52am
tags:
Pfizer, Japan, lung cancer, crizotinib
Drug-Resistant Germs Lure Biotechs to Lead Antibiotics Effort
Bloomberg
Tuesday, May 17, 2011 - 9:51am
tags:
antibiotics, biotech, Dificid, Optimer, Trius Therapeutics, Cubist Pharmaceuticals, Medicines Company
Merck closes acquisition of eye drug maker Inspire in deal worth $430M, or $5 per share
Yahoo/AP
Monday, May 16, 2011 - 2:18pm
tags:
Inspire, M&A, Merck
Merck's FDA Win Bodes Well for Vertex
Minyanville
Monday, May 16, 2011 - 2:17pm
tags:
Merck, FDA, Vertex Pharmaceuticals, hepatitis C, Telaprevir, Boceprevir
Cyclacel Pharmaceuticals: A Little Left on the Upside
Seeking Alpha
Monday, May 16, 2011 - 11:57am
tags:
Cyclacel, earnings
Look for Spectrum Pharmaceuticals to Rebound Short-Term
Seeking Alpha
Monday, May 16, 2011 - 11:56am
tags:
Spectrum Pharmaceuticals
Affymetrix's Management Is Creating Value
Motley Fool
Monday, May 16, 2011 - 11:55am
tags:
Affymetrix

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.